| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 5, 2004
From Pfizer Global Research and Development (M.K.), Groton, Conn; the University Department of Medicine and Therapeutics (K.R.L.), Gardiner Institute, Western Infirmary, Glasgow, UK; and the Department of Biostatistics (D.A.B.), M. D. Anderson, Houston, Tex. * To whom correspondence should be addressed. E-mail: dberry{at}mdanderson.org.
Revised on January 26, 2005
Accepted on January 28, 2005
The Past Is the Future. Innovative Designs in Acute Stroke Therapy Trials
Michael Krams MD;
Key words: models, theoretical
neuroprotection
This article has been cited by other articles:
![]() |
G. Howard Nonconventional Clinical Trial Designs: Approaches to Provide More Precise Estimates of Treatment Effects With a Smaller Sample Size, but at a Cost Stroke, February 1, 2007; 38(2): 804 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Dobkin Rehabilitation and Functional Neuroimaging Dose-Response Trajectories for Clinical Trials Neurorehabil Neural Repair, December 1, 2005; 19(4): 276 - 282. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |